Abstract:The post-transcriptional regulation of gene expression plays an important role in heart development and disease. Cardiac-specific alternative splicing, mediated by RNA-binding proteins, orchestrates the isoform switching of proteins that are essential for cardiomyocyte organization and contraction. Dysfunctions of RNA-binding proteins impair heart development and cause the main types of cardiomyopathies, which represent a heterogenous group of abnormalities that severely affect heart structure and function. In particular, mutations of RBM20 and RBFOX2 are associated with dilated cardiomyopathy, hypertrophic cardiomyopathy, or hypoplastic left heart syndrome. Functional analyses in different animal models also suggest possible roles for other RNA-binding proteins in cardiomyopathies because of their involvement in organizing cardiac gene programming. Recent studies have provided significant insights into the causal relationship between RNA-binding proteins and cardiovascular diseases. They also show the potential of correcting pathogenic mutations in RNA-binding proteins to rescue cardiomyopathy or promote cardiac regeneration. Therefore, RNA-binding proteins have emerged as promising targets for therapeutic interventions for cardiovascular dysfunction. The challenge remains to decipher how they coordinately regulate the temporal and spatial expression of target genes to ensure heart function and homeostasis. This review discusses recent advances in understanding the implications of several well-characterized RNA-binding proteins in cardiomyopathies, with the aim of identifying research gaps to promote further investigation in this field.

RNA Binding Proteins: Mechanistic Considerations and Perspectives in Controlling Cardiovascular Diseases

The Biological Mechanisms and Clinical Roles of RNA-Binding Proteins in Cardiovascular Diseases

RNA-Binding Proteins in Cardiomyopathies

RNA binding proteins as mediators of pathological cardiac remodeling

Adenosine Deaminase Acting on RNA 1 (ADAR1) As Crucial Regulators in Cardiovascular Diseases: Structures, Pathogenesis, and Potential Therapeutic Approach

Current RNA strategies in treating cardiovascular diseases

RNA modification in cardiovascular disease: implications for therapeutic interventions

RNA-binding proteins in cardiovascular biology and disease: the beat goes on

RNA-Binding Proteins: Emerging Therapeutics for Vascular Dysfunction

The regulation of circRNA and lncRNA protein binding in cardiovascular diseases: Emerging therapeutic targets

RNA modifications in cardiovascular diseases, the potential therapeutic targets

Advances in the study of RNA-binding proteins in diabetic complications

Recent Progress in the Research on RNA-Binding Proteins in Bone Development and Diseases

Piwi-interacting RNAs (piRNAs) as potential biomarkers and therapeutic targets for cardiovascular diseases

RNA Binding Proteins as Potential Therapeutic Targets in Colorectal Cancer

RNA-binding proteins in human genetic disease

CircRNA-mediated regulation of cardiovascular disease

piRNAs as emerging biomarkers and physiological regulatory molecules in cardiovascular disease

New insights into the function and therapeutic potential of RNA-binding protein TRBP in viral infection, chronic metabolic diseases, brain disorders and cancer

RNA in cardiovascular disease: A new frontier of personalized medicine

Long noncoding RNA/circular noncoding RNA-miRNA-mRNA axes in cardiovascular diseases